In an in vitro study relevant to IBD, butyrate and propionate were found to be more effective than acetate in inhibiting LPS-induced TNFα production from neutrophils and TNFα-mediated NF-κB activation in the human colon adenocarcinoma cell line [84]. Here, TNF is linked to inflammatory bowel disease.